| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/12/2004 | EP1417320A2 Transgenic plants expressing cobalamin binding proteins |
| 05/12/2004 | EP1417309A2 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 05/12/2004 | EP1417308A1 Human protooncogene kg-20 and protein encoded therein |
| 05/12/2004 | EP1417307A2 Oligonucleotide compositions and their use to induce apoptosis |
| 05/12/2004 | EP1417300A1 Process for the maturation of dentritic cells and a vaccine |
| 05/12/2004 | EP1417297A2 Leukemogenic transcription factors |
| 05/12/2004 | EP1417231A2 Modified human thymic stromal lymphopoietin |
| 05/12/2004 | EP1417230A2 Neuregulin-beta isoforms associated with neuronal processes |
| 05/12/2004 | EP1417229A2 Methods and compounds for the targeting of protein to exosomes |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417226A1 Derp1 and proderp1 allergen derivatives |
| 05/12/2004 | EP1417224A2 Secreted proteins |
| 05/12/2004 | EP1417223A1 Process for preparing lipid ii |
| 05/12/2004 | EP1417222A1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralzing annti-p17 antibodies which specifically recognize said neutralizing epitope |
| 05/12/2004 | EP1417220A2 Irreversible cysteine protease inhibitors of legumain |
| 05/12/2004 | EP1417217A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 05/12/2004 | EP1417216A2 Antisense modulation of bcl2-associated x protein expression |
| 05/12/2004 | EP1417215A1 Antisense modulation of cd40 ligand expression |
| 05/12/2004 | EP1417214A2 Cancer specific oligosaccharide sequences and use thereof |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416977A2 Device for regeneration of articular cartilage and other tissue |
| 05/12/2004 | EP1416974A1 Gas microsphere liposome composites |
| 05/12/2004 | EP1416972A2 Chimeric molecules to modulate gene expression |
| 05/12/2004 | EP1416971A1 Gene transfer imaging and uses thereof |
| 05/12/2004 | EP1416961A1 Composition and method for the treatment of disease |
| 05/12/2004 | EP1416957A2 Treatment of immune disorders and b cell disorders |
| 05/12/2004 | EP1416954A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 05/12/2004 | EP1416953A1 Methods of treating liver fibrosis |
| 05/12/2004 | EP1416952A1 Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases |
| 05/12/2004 | EP1416951A1 Melanin-concentrating hormone antagonists |
| 05/12/2004 | EP1416934A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416932A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |
| 05/12/2004 | EP1416915A1 Enhanced pharmacokinetic profile of hydrophobic substances |
| 05/12/2004 | EP1416885A2 Methods and devices for delivery of therapeutic capable agents with variable release profile |
| 05/12/2004 | EP1416884A2 Delivery of therapeutic capable agents |
| 05/12/2004 | EP1339378A4 Use of cyclosporin a 7-thioamide derivatives for hair growth |
| 05/12/2004 | EP1303284A4 Compositions and methods for the treatment of skin damage |
| 05/12/2004 | EP1226267B1 Process for producing a product containing antihypertensive tripeptides |
| 05/12/2004 | EP1196030B1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 05/12/2004 | EP1194531B1 Cyclic peptidomimetic urokinase receptor antagonists |
| 05/12/2004 | EP1131067B1 Composition and use of rar antagonists for promoting chondrogenesis |
| 05/12/2004 | EP1119254A4 Novel treatment for stroke management |
| 05/12/2004 | EP1068757B1 A method for controlling connections to a mobile station |
| 05/12/2004 | EP1066316B1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 05/12/2004 | EP1019027A4 Implantable collagen-containing putty material |
| 05/12/2004 | EP1007556B1 Troponin subunits and fragments useful as angiogenesis inhibitors |
| 05/12/2004 | EP0971731B1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 05/12/2004 | EP0969720A4 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | EP0914446B1 Cytochrome p450 expression in enterobacteria |
| 05/12/2004 | EP0862444B1 Treatment of dilated cardiomyopathy by removal of autoantibodies |
| 05/12/2004 | EP0833911B1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| 05/12/2004 | EP0826005B1 Use of avian, vitellin antibodies directed against hiv antigens for the manufacture of pharmaceutical preparations |
| 05/12/2004 | EP0815240B1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 05/12/2004 | EP0804577B1 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 05/12/2004 | EP0792156B1 Medicaments for the prevention or treatment of vascular hemorrhaging |
| 05/12/2004 | EP0781092B1 Nucleic acid encoding adenovirus e1a polypeptide for sensitizing tumor cells to chemotherapy or irradiation |
| 05/12/2004 | EP0627912B1 Gels for encapsulation of biological materials |
| 05/12/2004 | CN1496369A Modified interferon beta with reduced immunogenicity |
| 05/12/2004 | CN1496368A Immunopotentiators |
| 05/12/2004 | CN1496351A 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 05/12/2004 | CN1496271A Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 05/12/2004 | CN1496269A Medical composition containing P43 protein and taxol for curing cancer, curing method and use using the same thereof |
| 05/12/2004 | CN1496268A Vesicular stromatitis virus (VSV) |
| 05/12/2004 | CN1496263A Use of anfigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
| 05/12/2004 | CN1496256A Combination of EPOTHILONE analogs and chemotherapeutic agents for treatment of proliferative diseases |
| 05/12/2004 | CN1495262A Non-splicing variant of gp 350/220 |
| 05/12/2004 | CN1495258A Human tissue inhibitor of metalloprotease-4 |
| 05/12/2004 | CN1495254A Using phenylethyl caffeiate derivative, capsaicin and resin toxin to inhibit NF-KB |
| 05/12/2004 | CN1495253A Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method |
| 05/12/2004 | CN1495198A Analogs of glucagon-like peptide-1 |
| 05/12/2004 | CN1495197A G-CSF analogs composition and its preparation method |
| 05/12/2004 | CN1495195A Transgenic animal for expressing androgen receptor compound relatea protein |
| 05/12/2004 | CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 05/12/2004 | CN1494921A Erythropoietin oral lozenge and its preparation method |
| 05/12/2004 | CN1494920A Soft capsule preparation containing cyclosporin |
| 05/12/2004 | CN1494919A Embonate medicine composition containing bombesin-like product |
| 05/12/2004 | CN1494905A Medicine composition containing anti-tumor medicine and hydroximic acid derivative and having anti-tumor enhanced acitity and/or reducing side effect |
| 05/12/2004 | CN1494900A Slow releasing composition and its preparing method |
| 05/12/2004 | CN1149288C Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 05/12/2004 | CN1149287C Recombinant mersacidin and method for production |
| 05/12/2004 | CN1149286C Ligand polypeptides for the G-protein-coupled recetpor protein, their production and use |
| 05/12/2004 | CN1149283C Stable transglutaminase preparations and processer for producing them |
| 05/12/2004 | CN1149280C Replacement therapy for dental caries |
| 05/12/2004 | CN1149224C Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 05/12/2004 | CN1149223C Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/12/2004 | CN1149210C Thrombin inhibitors |
| 05/12/2004 | CN1149088C Bone growth promoting composition and its use |
| 05/12/2004 | CN1149076C Preparation of powder agglomerates |
| 05/11/2004 | US6734289 Gastrokines and derived peptides including inhibitors |
| 05/11/2004 | US6734286 Interleukin-5 specific recombinant antibodies |
| 05/11/2004 | US6734285 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, inflammation, diabetic retinopathy, rheumatoid arthritis and psoriasis |
| 05/11/2004 | US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence |
| 05/11/2004 | US6734211 Compositions and methods for promoting nerve regeneration |
| 05/11/2004 | US6734210 Therapeutically improved salts of azelaic acid |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734174 Modulators of the function of receptors of the TNF/NGF receptor |